Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE704
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,968
Award facts
- Contract value 100% obligated
- $19,967.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $20,000 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 9, 2026. This competitively awarded, non-set-aside delivery order is scheduled for completion by January 12, 2026, with performance conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, eczema, and certain respiratory conditions, representing a specialized pharmaceutical supply requirement typical of federal military healthcare procurement.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2031. This primary IDC vehicle enables Cencora to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities, the Defense Health Agency, and other federal healthcare systems globally. AmerisourceBergen, as a major pharmaceutical distributor, serves as a critical vendor in the federal medical supply chain, consistently fulfilling competitive contract requirements across multiple therapeutic domains for military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FE704?
SPE2DR26FE704 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FE704 worth?
The government has obligated $19,968 on SPE2DR26FE704.
Is contract SPE2DR26FE704 an order under another contract?
Yes. SPE2DR26FE704 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE704 competed?
The extent of competition for SPE2DR26FE704 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award